Search Results - "Ilham, Sabrina"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Cancer incidence in immunocompromised patients: a single-center cohort study by Ilham, Sabrina, Willis, Connor, Kim, Kibum, Chung, Karen C, Wood, Brenda M, Tan, Malinda S, Tan, Chia Jie, Nguyen, Danielle T, Brixner, Diana I, Stenehjem, David D

    Published in BMC cancer (09-01-2023)
    “…Diminished immune defense plays an important role in cancer development. Cancer risk in immunocompromised patients may differ. Identifying individuals with…”
    Get full text
    Journal Article
  2. 2

    Proportion of US Hospitalized Medically Ill Patients Who May Qualify for Extended Thromboprophylaxis by Miao, Benjamin, Chalupadi, Bhavana, Clark, Brendan, Descoteaux, Alexis, Huang, Daniel, Ilham, Sabrina, Ly, Brian, Spyropoulos, Alex C., Coleman, Craig I.

    Published in Clinical and applied thrombosis/hemostasis (01-01-2019)
    “…Extended thromboprophylaxis with oral anticoagulation can reduce the risk of symptomatic venous thromboembolism (VTE) in high-risk patients. We sought to…”
    Get full text
    Journal Article
  3. 3

    Positive Association between Peri-Surgical Opioid Exposure and Post-Discharge Opioid-Related Outcomes by Kim, Kibum, Biskupiak, Joseph E, Babin, Jennifer L, Ilham, Sabrina

    Published in Healthcare (Basel) (30-12-2022)
    “…Background: Multiple studies have investigated the epidemic of persistent opioid use as a common postsurgical complication. However, there exists a knowledge…”
    Get full text
    Journal Article
  4. 4

    Modeling the population health impact of incorporating a multi-cancer early detection (MCED) test to existing cancer screening among immunocompromised individuals by Tan, Chia Jie, Ilham, Sabrina, Willis, Connor, Kim, Ashley, Cong, Ze, Brixner, Diana, Stenehjem, David

    Published in Current medical research and opinion (01-09-2024)
    “…To assess the screening efficiency of an multi-cancer early detection (MCED) test added to standard of care (SoC) screening, compared to SoC screening alone,…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Risk of Bleeding Among Individuals on Direct-Acting Oral Anticoagulants: An Academic Medical Center Cohort Study by Gomez Lumbreras, Ainhoa, Tan, Malinda S., Moorman-Bishir, Krystal, Ilham, Sabrina, Malone, Daniel C.

    Published in Journal of cardiovascular pharmacology (01-12-2022)
    “…Previous research has identified risk factors that may affect the risk of bleeding when individuals are exposed to oral anticoagulants. It is unclear if the…”
    Get full text
    Journal Article
  9. 9

    Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective by Gómez Lumbreras, Ainhoa, Tan, Malinda S., Villa-Zapata, Lorenzo, Ilham, Sabrina, Earl, Jacob C., Malone, Daniel C.

    “…To determine the cost-effectiveness of anti-obesity medications (AOM): tirzepatide, semaglutide, liraglutide, phentermine plus topiramate (PpT), and naltrexone…”
    Get full text
    Journal Article
  10. 10

    The implementation of value-based frameworks, clinical care pathways, and alternative payment models for cancer care in the United States by Panchal, Rupesh, Brendle, Madeline, Ilham, Sabrina, Kharat, Aditi, Schmutz, Howard W., Huggar, David, McBride, Ali, Copher, Ronda, Au, Trang, Willis, Connor, Brixner, Diana

    “…BACKGROUND: Cancer treatment is a significant driver of rising health care costs in the United States, where the annual cost of cancer care is estimated to…”
    Get full text
    Journal Article
  11. 11

    Meta‐Analysis of Time in Therapeutic Range in Continuous‐Flow Left Ventricular Assist Device Patients Receiving Warfarin by Martinez, Brandon K., Yik, Brenda, Tran, Raymond, Ilham, Sabrina, Coleman, Craig I., Jennings, Douglas L., Baker, William L.

    Published in Artificial organs (01-07-2018)
    “…Continuous‐flow left ventricular assist devices (CF‐LVADs) prolong survival in advanced heart failure patients. Anticoagulation control is critical in CF‐LVAD…”
    Get full text
    Journal Article
  12. 12

    Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain by Merino-Torres, Juan Francisco, Ilham, Sabrina, Alshannaq, Hamza, Pollock, Richard, Ahmed, Waqas, Norman, Gregory

    Published in ClinicoEconomics and outcomes research (01-11-2024)
    “…Management of advanced type 2 diabetes (T2D) typically involves daily insulin therapy alongside frequent blood glucose monitoring, as treatments such as oral…”
    Get full text
    Journal Article